The earnings call reflected a strong quarter characterized by significant growth in various divisions and successful strategic investments in advertising and innovation. However, there were some challenges in North America and specific segments like Skin Health, as well as ongoing volatility in emerging markets.

Company Guidance

In the third quarter of 2024 earnings call, Colgate-Palmolive provided guidance reflecting strong financial performance and strategic focus. The company reported organic sales growth with volume growth of 3% in developed markets and 4.6% in emerging markets. This growth was attributed to impactful core and premium innovation, increased advertising spending, and improved brand health. Additionally, the gross profit margin expanded by 270 basis points year-on-year, enabling continued investment in advertising and capabilities. The company emphasized its ability to convert organic sales growth into consistent earnings per share growth, supporting top-tier total shareholder return (TSR) over the long term. Colgate-Palmolive also discussed its strategic initiatives in North America and emerging markets, addressing pricing, volume, and innovation to sustain future growth.

Strong Volume-Led Organic Sales Growth

Volume growth in all 6 divisions for the second straight quarter, with 3% growth in developed markets and 4.6% growth in emerging markets.

Gross Margin Improvement

Gross profit margin up 270 basis points year-on-year, with strong gross margin dollar growth.

Hill's Pet Nutrition Performance

Hill's business reported strong volume growth, mid-single digits excluding private label, with significant margin performance.

Robust Performance in Europe

Strong volume growth in Europe with improved market shares, particularly in Oral Care, reaching record high levels.

Emerging Markets Contribution

Strong organic sales growth in emerging markets, with positive volume and pricing, particularly in Brazil, India, and Mexico.

Advertising and Innovation Investment

Increased investment in advertising and innovation leading to improved brand health and household penetration.

---

Colgate-Palmolive (CL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CL Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Jan 31, 2025	2024 (Q4)	0.90 / -	0.87	―	―	―
Oct 25, 2024	2024 (Q3)	0.89 / 0.91	0.86	5.81% (+0.05)
Jul 26, 2024	2024 (Q2)	0.87 / 0.91	0.77	18.18% (+0.14)
Apr 26, 2024	2024 (Q1)	0.81 / 0.86	0.73	17.81% (+0.13)
Jan 26, 2024	2023 (Q4)	0.85 / 0.87	0.77	12.99% (+0.10)
Oct 27, 2023	2023 (Q3)	0.80 / 0.86	0.74	16.22% (+0.12)
Jul 28, 2023	2023 (Q2)	0.75 / 0.77	0.72	6.94% (+0.05)
Apr 28, 2023	2023 (Q1)	0.70 / 0.73	0.74	-1.35% (-0.01)
Jan 27, 2023	2022 (Q4)	0.76 / 0.77	0.79	-2.53% (-0.02)
Oct 28, 2022	2022 (Q3)	0.73 / 0.74	0.81	-8.64% (-0.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

---

CL Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Oct 25, 2024	$99.74	$95.61	-4.14%
Jul 26, 2024	$96.01	$98.90	+3.01%
Apr 26, 2024	$88.39	$90.10	+1.93%
Jan 26, 2024	$79.94	$81.53	+1.99%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

---